-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ptc Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2011 to Q3 2025.
- Ptc Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 87.1M shares, a 13.2% increase year-over-year.
- Ptc Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 76.8M shares, a 2.68% increase from 2023.
- Ptc Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 74.8M shares, a 4.34% increase from 2022.
- Ptc Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 71.7M shares, a 1.79% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)